A Phase IIb Study to Evaluate the Safety of Zibotentan/Dapagliflozin in Participants With Cirrhosis-ZEAL-UNLOCK

NCT06269484 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

73

Enrollment

INDUSTRY

Sponsor class

Conditions

Liver Cirrhosis

Interventions

DRUG: Placebo (placebo matching zibotentan capsule and placebo matching dapagliflozin tablet)
DRUG: Zibotentan + placebo (placebo matching dapagliflozin tablet)
DRUG: Zibotentan + dapagliflozin

Sponsor

AstraZeneca